Literature DB >> 28617552

Long non-coding RNA TUG1 can promote proliferation and migration of pancreatic cancer via EMT pathway.

C-F Qin1, F-L Zhao.   

Abstract

OBJECTIVE: This paper aimed to investigate the effect of long non-coding RNA TUG1 (lncRNA TUG1) on cell proliferation, as well as cell migration in pancreatic cancer. PATIENTS AND METHODS: The mRNA levels of Taurine-up-regulated gene 1 (TUG1) in three kinds of pancreatic cancer cells BxPC3, PaTu8988 and SW1990 was detected by RT-qPCR. Meantime, RT-qPCR was used to examine the mRNA levels of TUG1 in 20 cases of human pancreatic cancer tissues and its para-carcinoma tissues. pCDH-TUG1 plasmid and its empty plasmid pCDH were transfected into BxPC3 and PaTu8988 cells to up-regulate TUG1 expression. siRNA targeting TUG1 and the control siRNA were transfected into SW1990 cells to down-regulate TUG1 expression. Cell clone formation and CCK-8 assay were used to detect the cell proliferation capacity. Transwell assay was used to evaluate cell migration capacity. Western blot was applied to examine the protein expressions of MMP2, MMP9, E-cadherin, Smad 2, Smad 3, p-Smad 2, p-Smad 3, TGF-β and TGF-βR. RT-qPCR was used to detect the levels of MMP2 and MMP9.
RESULTS: The results showed that TUG1 was differentially expressed in the three kinds of pancreatic cancer cells, among which the expression level of SW1990 was relatively high, and the expression levels of BxPC3 and PaTu8988 were relatively low. TUG1 had more expression in pancreatic cancer tissues than that in para-carcinoma tissues. After the up-regulation of TUG1, cell proliferation and migration capacities were increased, protein levels of MMP2 and MMP9 were increased and protein level of E-cadherin was declined. Conversely, after down-regulation of TUG1 expression, cell proliferation and migration capacities were weakened, protein levels of MMP2 and MMP9 were decreased and protein level of E-cadherin was increased. In addition, over-expressed TUG1 could promote Smad2 and Smad3 phosphorylation, but Smad2 and Smad3 phosphorylation were weakened after down-regulated expression of TUG1. The protein expression of TGF-β and TGF-β receptor were more in the TUG1 overexpression group than that in the control group, while the result was just opposite after TUG1 expression was down-regulated.
CONCLUSIONS: These data suggest that lncRNA TUG1 may enhance the proliferation and migration of pancreatic cancer cells through EMT pathway.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28617552

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  27 in total

Review 1.  Role of taurine, its haloamines and its lncRNA TUG1 in both inflammation and cancer progression. On the road to therapeutics? (Review).

Authors:  Stella Baliou; Anthony M Kyriakopoulos; Demetrios A Spandidos; Vassilios Zoumpourlis
Journal:  Int J Oncol       Date:  2020-07-14       Impact factor: 5.650

2.  Knockdown of long non-coding RNA AFAP1-AS1 inhibits growth and promotes apoptosis in pituitary adenomas.

Authors:  Hengxin Tang; Bo Hou; Zhuopeng Ye; Cong Ling; Ying Guo
Journal:  Int J Clin Exp Pathol       Date:  2018-03-01

3.  Persistence of Drug-Resistant Leukemic Stem Cells and Impaired NK Cell Immunity in CML Patients Depend on MIR300 Antiproliferative and PP2A-Activating Functions.

Authors:  Giovannino Silvestri; Rossana Trotta; Lorenzo Stramucci; Justin J Ellis; Jason G Harb; Paolo Neviani; Shuzhen Wang; Ann-Kathrin Eisfeld; Christopher J Walker; Bin Zhang; Klara Srutova; Carlo Gambacorti-Passerini; Gabriel Pineda; Catriona H M Jamieson; Fabio Stagno; Paolo Vigneri; Georgios Nteliopoulos; Philippa C May; Alistair G Reid; Ramiro Garzon; Denis-Claude Roy; Moutuaata M Moutuou; Martin Guimond; Peter Hokland; Michael W Deininger; Garrett Fitzgerald; Christopher Harman; Francesco Dazzi; Dragana Milojkovic; Jane F Apperley; Guido Marcucci; Jianfei Qi; Katerina Machova Polakova; Ying Zou; Xiaoxuan Fan; Maria R Baer; Bruno Calabretta; Danilo Perrotti
Journal:  Blood Cancer Discov       Date:  2020-07

4.  Hypoxia induced-disruption of lncRNA TUG1/PRC2 interaction impairs human trophoblast invasion through epigenetically activating Nodal/ALK7 signalling.

Authors:  Mengsi Hu; Yao Wang; Yanping Meng; Jinxiu Hu; Jiao Qiao; Junhui Zhen; Decai Liang; Minghua Fan
Journal:  J Cell Mol Med       Date:  2022-06-21       Impact factor: 5.295

5.  Long non-coding RNA SUMO1P3 may promote cell proliferation, migration, and invasion of pancreatic cancer via EMT signaling pathway.

Authors:  Chuang Tian; Yong Jin; Songshan Shi
Journal:  Oncol Lett       Date:  2018-09-03       Impact factor: 2.967

6.  Expression of Long Non-Coding RNAs in Placentas of Intrauterine Growth Restriction (IUGR) Pregnancies.

Authors:  Iman Azari; Soudeh Ghafouri-Fard; Mir Davood Omrani; Shahram Arsang-Jang; Dor Mohammad Kordi Tamandani; Mehrnaz Saroone Rigi; Sara Rafiee; Farkhondeh Pouresmaeili; Mohammad Taheri
Journal:  Rep Biochem Mol Biol       Date:  2019-04

7.  Prognostic value of long non-coding RNA TUG1 in various tumors.

Authors:  Na Li; Ke Shi; Xinmei Kang; Wei Li
Journal:  Oncotarget       Date:  2017-08-07

8.  Curative effect of minimally invasive surgery on palmar and foot hyperhidrosis and its influence on serum-related cytokines and immunoglobulins.

Authors:  Wei Xi Li; Yong Kun Li; Hai Tao Lin
Journal:  Exp Ther Med       Date:  2018-02-15       Impact factor: 2.447

9.  Long Noncoding RNA Taurine-Upregulated Gene1 (TUG1) Promotes Tumor Growth and Metastasis Through TUG1/Mir-129-5p/Astrocyte-Elevated Gene-1 (AEG-1) Axis in Malignant Melanoma.

Authors:  Jianwen Long; Qiqige Menggen; Qimige Wuren; Quan Shi; Xianming Pi
Journal:  Med Sci Monit       Date:  2018-03-15

10.  Linc00462 promotes pancreatic cancer invasiveness through the miR-665/TGFBR1-TGFBR2/SMAD2/3 pathway.

Authors:  Bin Zhou; Weidong Guo; Chuandong Sun; Bingyuan Zhang; Fang Zheng
Journal:  Cell Death Dis       Date:  2018-06-13       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.